Do you know that the most dangerous animal bite in the world is also the most common and often goes unnoticed?
Caused by the deadliest insect in the world, the Aedes aegypti mosquito, dengue is the most rapidly spreading mosquito-borne disease in the world and is more rampant in countries with tropical climates like the Philippines.
Dengue affects more children than adults, with kids one to nine years old as the most vulnerable victims because of their predilection to mosquito bites. In some regions, dengue has reached epidemic proportions.
Jeoffrey Yulo GM GSK Consumer Health, Evelyn Perez DOH Infectious Deseases Committee and Dr Sally Gatchalian, PPS Secretary
Unite Against Dengue
GlaxoSmithKline, one of the world’s leading research-based pharmaceutical and healthcare companies and maker of doctor-recommended Paracetamol Calpol, joins forces with the Department of Health and the Philippine Pediatric Society is spearheading a campaign called “Aksyon Laban sa Dengue: A Dengue Fever Awareness and Education Program” as well as a Barangay Caravan that will bring dengue fever awareness efforts to the grassroots level.
The World Health Organization has recommended Paracetamol as the preferred and only recommended analgesic treatment for Dengue Fever. Aspirin or ibuprofen is not advised as these drugs may aggravate bleeding.
Calpol®, a product of GSK, contains Paracetamol specially designed to offer effective relief from the discomforts of pain and fever among children. Calpol® also has the broad suitability associated with standard paracetamol so you can be assured that it won’t harm your child when used as directed.
Engaging the Barangays
Eliminating dengue must be a community effort. One such remarkable initiative is the partnership of the DOH, the PPS, and GlaxoSmithKline, the maker of doctor-recommended Paracetamol Calpol which targets selected barangays within Metro Manila with identified high cases of dengue incidence.
Moms Taking their commitment against Dengue
The DOH will initially be facilitating the training of health practitioners to discuss new dengue incidence and disease trends as well as updates on its prevention and treatment guidelines. The PPS health committee will then cascade these dengue modules based on DOH guidelines with the selected barangays. On its part, GSK will be bringing doctors to these areas to lead the Dengue information campaign to help Filipinos protect their families and loved ones from this deadly menace.
If symptoms persist, consult your doctor. For more information about (Paracetamol) Calpol®, and its Dengue campaign, visit www.calpol.com.ph.
